IWR-1-endo

Catalog No.S7086 Batch:S708604

Print

Technical Data

Formula

C25H19N3O3
Molecular Weight 409.44 CAS No. 1127442-82-3
Solubility (25°C)* In vitro DMSO 82 mg/mL (200.27 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO Corn oil
1.5mg/ml Taking the 1 mL working solution as an example, add 50 μL of 30 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
4.1mg/ml Taking the 1 mL working solution as an example, add 50 μL of 82 mg/ml clarified DMSO stock solution to 400 μL PEG300, mix evenly to clarify it; add 50 μL Tween80 to the above system, mix evenly to clarify it; then continue to add 500 μL ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description IWR-1-endo (endo-IWR 1, IWR-1) is a Wnt pathway inhibitor with IC50 of 180 nM in L-cells expressing Wnt3A, induces Axin2 protein levels and promotes β-catenin phosphorylation by stabilizing Axin-scaffolded destruction complexes.
Targets
Wnt [1]
(L-cells expressing Wnt3A)
180 nM
In vitro

Although both IWR-1 and XAV939 act as reversible Wnt pathway inhibitors and exhibit similar pharmacological effects both in vitro and in vivo, IWR-1 exerts its effect via interaction with Axin, while XAV939 binds TNKS directly. [1]
In vivo

IWR-1 is a β‐catenin inhibitor.[3]

Protocol (from reference)

Cell Assay:

[2]
  • Cell lines

    Pig EpiSCs

  • Concentrations

    2.5 μM

  • Incubation Time

    2 days

  • Method

    For neural induction, the 3i/LAF culture medium was replaced with neural induction medium I (2.5 μM IWR-1-endo, 5 μM SB431542, and 10 ng/mL FGF2 in BM) on day 2 after pgEpiSC passage.

Customer Product Validation

Data from [Data independently produced by , , Diabetes, 2018, 67(4):554-568]

Data from [Data independently produced by , , Biochim Biophys Acta Mol Cell Biol Lipids, 2018, 1863(8):834-843]

Data from [Data independently produced by , , Am J Cancer Res, 2015, 5(10):3123-3134.]

Selleck's IWR-1-endo has been cited by 140 publications

Electrically Conductive Collagen-PEDOT:PSS Hydrogel Prevents Post-Infarct Cardiac Arrhythmia and Supports hiPSC-Cardiomyocyte Function [ Adv Mater, 2024, e2403642] PubMed: 38653478
Distinct mechanisms regulate ventricular and atrial chamber wall formation [ Nat Commun, 2024, 15(1):8159] PubMed: 39289341
Derivation of human primordial germ cell-like cells in an embryonic-like culture [ Nat Commun, 2024, 15(1):167] PubMed: 38167821
Small molecule valproic acid enhances ventral patterning of human neural tube organoids by regulating Wnt and Shh signalling [ Cell Prolif, 2024, e13737.] PubMed: 39164046
Anti-Ferroptotic Treatment Deteriorates Myocardial Infarction by Inhibiting Angiogenesis and Altering Immune Response [ Antioxidants (Basel), 2024, 13(7)769] PubMed: 39061839
Cell size regulates human endoderm specification through actomyosin-dependent AMOT-YAP signaling [ Stem Cell Reports, 2024, 19(8):1137-1155] PubMed: 39094563
Autophagy is essential for human myelopoiesis [ Stem Cell Reports, 2024, 19(2):196-210] PubMed: 38215759
Cardiomyocyte-fibroblast interaction regulates ferroptosis and fibrosis after myocardial injury [ iScience, 2024, 27(3):109219] PubMed: 38469561
Inhibitor of Wnt receptor 1 suppresses the effects of Wnt1, Wnt3a and β‑catenin on the proliferation and migration of C6 GSCs induced by low‑dose radiation [ Oncol Rep, 2024, 51(2)22] PubMed: 38099414
Membrane Curvature Promotes ER-PM Contact Formation via Junctophilin-EHD Interactions [ bioRxiv, 2024, 2024.06.29.601287] PubMed: 38979311

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.